Bizily Scott bought FDMT
June 23, 2026 · Form 4 insider transaction
Bizily Scott bought 9,810 shares of 4D Molecular Therapeutics, Inc. at $4.14 per share, a transaction worth $40.6K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
9,810
Price
$4.14
Total value
$40.6K
InsiderBizily Scott
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 23, 2026
Filing dateJune 25, 2026
Shares owned after18,427
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Reflects 5,023 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.